NASDAQ : DNLI

Denali Therapeutics Inc. — Institutional Ownership

$24.17 USD

$1.02 (4.41%)

Volume
993.77K
Average Volume
1.92M
Market Capitalization
$3.84B
P/E Ratio
-8.39
Dividend Yield
0.00%
Price Target
$36.00
Year High
$27.30
Year Low
$12.58
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$9.28
Institutional Ownership Summary
Institutional Ownership %

4.57%

Investors Holding

67

change: -214 | last: 281
Increased Positions

44

change: -116 | last: 160
Reduced Positions

11

change: -48 | last: 59
New Positions

18

change: -38 | last: 56
Sold Positions

221

change: 186 | last: 35
Total Calls

-

Total Puts

-

Put-Call Ratio

0.00

change: -49.3368 | last: 0.4934
Total Invested

219.63M

Beneficial Ownership Filings
Filing Date Reporting Person Amount Beneficially Owned % of Class
2026-05-15 T. Rowe Price Investment Management, Inc. 8.52M 5.40%
2026-05-06 FMR LLC 6.67M 4.20%
2026-03-26 The Vanguard Group - 0.00%
2025-11-05 FMR LLC 8.54M 5.80%
2025-08-12 Wellington Management Group LLP 5.66M 3.90%
2025-04-17 BlackRock, Inc. 10.49M 7.20%
2025-02-13 Capital Research Global Investors 5.48M 3.80%
2025-02-12 BAILLIE GIFFORD & CO 12.31M 8.60%
2024-11-12 95-1411037 13.0 5.50%
2024-08-16 FMR LLC 7.19M 5.02%
2024-08-16 Abigail P. Johnson 7.19M 5.02%
2024-02-08 Wellington Group Holdings LLP 7.27M 5.26%
2024-02-08 Wellington Investment Advisors Holdings LLP 7.27M 5.26%
2024-02-08 Wellington Management Group LLP 7.27M 5.26%
2024-02-08 Wellington Management Company LLP 7.18M 5.19%
2023-03-30 5.0%(1)(2) 6.9M 5.00%
2022-02-14 Crestline Management, L.P. 7.71M 6.30%
2022-02-14 Crestline Investors, Inc. 7.71M 6.30%
2022-02-14 52-0556948 4.64M 3.70%
2022-02-14 Douglas K. Bratton 7.85M 6.40%
2022-02-14 Crestline SI (GP), L.P. 7.71M 6.30%
2022-02-14 AKDL, L.P. 7.71M 6.30%
2022-02-09 The Vanguard Group - 23-1945930 8.16M 6.68%
2021-02-16 Fund V, L.P. 2.73M 2.20%
2021-02-16 52-0556948 6.46M 5.30%
2021-02-16 Fund V General Partner LLC 2.73M 2.20%
2021-02-16 Ph.D. 2.73M 2.20%
2021-02-02 (1) BlackRock, Inc. 6.38M 5.30%
2020-02-07 (1) BlackRock, Inc. 5.25M 5.50%
2018-02-02 Clinton Bybee 11.07M 12.30%
2018-02-02 ARCH Venture Fund VIII, L.P. 11.07M 12.30%
2018-02-02 ARCH Venture Partners VIII, L.P. 11.07M 12.30%
2018-02-02 ARCH Venture Partners VIII, LLC 11.07M 12.30%
2018-02-02 Keith Crandell 11.07M 12.30%
2018-02-02 Robert Nelsen 11.07M 12.30%
2018-01-31 Baillie Gifford & Co (Scottish partnership) 4.92M 11.00%
DNLI Enterprise Value History
Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2025-12-31 $16.51 175.46M $2.9B $205.33M $36.76M $2.73B
2024-12-31 $20.38 164.47M $3.35B $174.96M $48.71M $3.23B
2023-12-31 $21.46 137.37M $2.95B $127.11M $52.24M $2.87B
2022-12-31 $27.81 125.53M $3.49B $218.04M $60.35M $3.33B
2021-12-31 $44.60 121.52M $5.42B $293.48M $64.01M $5.19B
2020-12-31 $83.76 108.97M $9.13B $507.14M $68.86M $8.69B
2019-12-31 $17.42 95.61M $1.67B $79.45M $72.53M $1.66B
2018-12-31 $20.66 92.62M $1.91B $77.12M -$ $1.84B
2017-12-31 $15.64 14.96M $234.04M $218.38M -$ $15.66M
2016-12-31 $21.45 6.42M $137.81M $39.85M -$ $97.96M
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2026-03-31 $19.20 186.64M $3.58B $387.63M $40.05M $3.24B
2025-12-31 $16.51 175.46M $2.9B $205.33M $36.76M $2.73B
2025-09-30 $14.52 172.42M $2.5B $90.96M $44.4M $2.46B
2025-06-30 $13.99 171.45M $2.4B $141.21M $46.56M $2.3B
2025-03-31 $13.60 171.22M $2.33B $56.95M $48.63M $2.32B
2024-12-31 $20.38 170.09M $3.47B $174.96M $48.71M $3.34B
2024-09-30 $29.13 169.46M $4.94B $90.64M $52.52M $4.9B
2024-06-30 $22.01 168.83M $3.72B $74.68M $48.75M $3.69B
2024-03-31 $20.56 149.4M $3.07B $60.57M $50.55M $3.06B
2023-12-31 $21.46 138.25M $2.97B $127.11M $52.24M $2.89B
2023-09-30 $20.63 137.64M $2.84B $148.01M $53.9M $2.75B
2023-06-30 $29.51 137.05M $4.04B $131.97M $55.52M $3.97B